<?xml version='1.0' encoding='utf-8'?>
<document id="28650921"><sentence text="Effect of Continuity of Care on Drug-Drug Interactions." /><sentence text="Drug-drug interaction (DDI) is a critical concern in health care systems because it is directly associated with patient outcomes and is generally preventable" /><sentence text=" However, few studies have been conducted on whether poor continuity of care (COC) is a determinant of DDIs and whether this effect varies by level of comorbidity" /><sentence text=" Patients with higher comorbidity normally require more complex treatment regimens than other patients, and hence their COC is more critical for ensuring the accuracy of their medication information" /><sentence text="" /><sentence text="This study investigated the association between COC and DDI, with COC being measured as physician and site COC"><entity charOffset="66-69" id="DDI-PubMed.28650921.s6.e0" text="COC" /><entity charOffset="48-50" id="DDI-PubMed.28650921.s6.e1" text="COC" /><entity charOffset="107-109" id="DDI-PubMed.28650921.s6.e2" text="COC" /><pair ddi="false" e1="DDI-PubMed.28650921.s6.e1" e2="DDI-PubMed.28650921.s6.e1" /><pair ddi="false" e1="DDI-PubMed.28650921.s6.e1" e2="DDI-PubMed.28650921.s6.e0" /><pair ddi="false" e1="DDI-PubMed.28650921.s6.e1" e2="DDI-PubMed.28650921.s6.e2" /><pair ddi="false" e1="DDI-PubMed.28650921.s6.e0" e2="DDI-PubMed.28650921.s6.e0" /><pair ddi="false" e1="DDI-PubMed.28650921.s6.e0" e2="DDI-PubMed.28650921.s6.e2" /></sentence><sentence text=" The effect of comorbidities on DDI events was also analyzed" /><sentence text="" /><sentence text="The Taiwan National Health Insurance claims data of âˆ¼1,000,000 randomly selected insurance beneficiaries were used" /><sentence text=" Each person was longitudinally followed from 2005 to 2013" /><sentence text=" Negative nominal regressions were estimated to determine the effect of COC on DDI"><entity charOffset="72-75" id="DDI-PubMed.28650921.s11.e0" text="COC" /></sentence><sentence text="" /><sentence text="Higher COC was found to decrease the risk of DDI, and this risk reduction was even greater with physician COC and a higher Charlson comorbidity index"><entity charOffset="7-9" id="DDI-PubMed.28650921.s13.e0" text="COC" /><entity charOffset="106-108" id="DDI-PubMed.28650921.s13.e1" text="COC" /><pair ddi="false" e1="DDI-PubMed.28650921.s13.e0" e2="DDI-PubMed.28650921.s13.e0" /><pair ddi="false" e1="DDI-PubMed.28650921.s13.e0" e2="DDI-PubMed.28650921.s13.e1" /></sentence><sentence text=" In the 1-year observation interval, patients exhibited a 3% reduction in DDIs for every 0" /><sentence text="1 increment in their COC index"><entity charOffset="21-23" id="DDI-PubMed.28650921.s15.e0" text="COC" /></sentence><sentence text=" The ability of COC to reduce DDIs increased with the level of comorbidity"><entity charOffset="16-18" id="DDI-PubMed.28650921.s16.e0" text="COC" /></sentence><sentence text=" Similar results were observed when the observation interval was increased" /><sentence text="" /><sentence text="Improving COC is critical for reducing DDIs"><entity charOffset="10-12" id="DDI-PubMed.28650921.s19.e0" text="COC" /></sentence><sentence text=" The effect of high-quality COC on the reduction of DDI is more significant for patients with higher levels of comorbidity; thus, they should be targeted to improve COC"><entity charOffset="28-30" id="DDI-PubMed.28650921.s20.e0" text="COC" /><entity charOffset="165-167" id="DDI-PubMed.28650921.s20.e1" text="COC" /><pair ddi="false" e1="DDI-PubMed.28650921.s20.e0" e2="DDI-PubMed.28650921.s20.e0" /><pair ddi="false" e1="DDI-PubMed.28650921.s20.e0" e2="DDI-PubMed.28650921.s20.e1" /></sentence><sentence text="" /></document>